Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Cell‐permeable succinate rescues mitochondrial respiration in cellular models of amiodarone toxicity

Bețiu, Alina M. ; Chamkha, Imen LU ; Gustafsson, Ellen ; Meijer, Elna ; Avram, Vlad F. ; Frostner, Eleonor Åsander LU orcid ; Ehinger, Johannes K. LU orcid ; Petrescu, Lucian ; Muntean, Danina M. and Elmér, Eskil LU orcid (2021) In International Journal of Molecular Sciences 22(21).
Abstract

Amiodarone is a potent antiarrhythmic drug and displays substantial liver toxicity in hu-mans. It has previously been demonstrated that amiodarone and its metabolite (desethylamioda-rone, DEA) can inhibit mitochondrial function, particularly complexes I (CI) and II (CII) of the elec-tron transport system in various animal tissues and cell types. The present study, performed in human peripheral blood cells, and one liver‐derived human cell line, is primarily aimed at assessing the concentration‐dependent effects of these drugs on mitochondrial function (respiration and cellular ATP levels). Furthermore, we explore the efficacy of a novel cell‐permeable succinate prodrug in alleviating the drug‐induced acute mitochondrial dysfunction.... (More)

Amiodarone is a potent antiarrhythmic drug and displays substantial liver toxicity in hu-mans. It has previously been demonstrated that amiodarone and its metabolite (desethylamioda-rone, DEA) can inhibit mitochondrial function, particularly complexes I (CI) and II (CII) of the elec-tron transport system in various animal tissues and cell types. The present study, performed in human peripheral blood cells, and one liver‐derived human cell line, is primarily aimed at assessing the concentration‐dependent effects of these drugs on mitochondrial function (respiration and cellular ATP levels). Furthermore, we explore the efficacy of a novel cell‐permeable succinate prodrug in alleviating the drug‐induced acute mitochondrial dysfunction. Amiodarone and DEA elicit a con-centration‐dependent impairment of mitochondrial respiration in both intact and permeabilized platelets via the inhibition of both CI‐ and CII‐supported respiration. The inhibitory effect seen in human platelets is also confirmed in mononuclear cells (PBMCs) and HepG2 cells. Additionally, amiodarone elicits a severe concentration‐dependent ATP depletion in PBMCs, which cannot be explained solely by mitochondrial inhibition. The succinate prodrug NV118 alleviates the respiratory deficit in platelets and HepG2 cells acutely exposed to amiodarone. In conclusion, amiodarone severely inhibits metabolism in primary human mitochondria, which can be counteracted by in-creasing mitochondrial function using intracellular delivery of succinate.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Amiodarone, ATP, Desethylamiodarone, HepG2 cells, Mito-chondria, NV118, PBMCs, Platelets, Respiration, Sotalol
in
International Journal of Molecular Sciences
volume
22
issue
21
article number
11786
publisher
MDPI AG
external identifiers
  • pmid:34769217
  • scopus:85117932102
ISSN
1661-6596
DOI
10.3390/ijms222111786
project
Mitochondrial dysfunction in drug and chemical toxicity: mechanism, target identification and therapeutic development
language
English
LU publication?
yes
additional info
Publisher Copyright: © by the authors. Licensee MDPI, Basel, Switzerland.
id
79de9ede-a2bd-4e32-809c-3b22cfb22436
date added to LUP
2021-11-22 13:54:56
date last changed
2024-09-08 05:13:51
@article{79de9ede-a2bd-4e32-809c-3b22cfb22436,
  abstract     = {{<p>Amiodarone is a potent antiarrhythmic drug and displays substantial liver toxicity in hu-mans. It has previously been demonstrated that amiodarone and its metabolite (desethylamioda-rone, DEA) can inhibit mitochondrial function, particularly complexes I (CI) and II (CII) of the elec-tron transport system in various animal tissues and cell types. The present study, performed in human peripheral blood cells, and one liver‐derived human cell line, is primarily aimed at assessing the concentration‐dependent effects of these drugs on mitochondrial function (respiration and cellular ATP levels). Furthermore, we explore the efficacy of a novel cell‐permeable succinate prodrug in alleviating the drug‐induced acute mitochondrial dysfunction. Amiodarone and DEA elicit a con-centration‐dependent impairment of mitochondrial respiration in both intact and permeabilized platelets via the inhibition of both CI‐ and CII‐supported respiration. The inhibitory effect seen in human platelets is also confirmed in mononuclear cells (PBMCs) and HepG2 cells. Additionally, amiodarone elicits a severe concentration‐dependent ATP depletion in PBMCs, which cannot be explained solely by mitochondrial inhibition. The succinate prodrug NV118 alleviates the respiratory deficit in platelets and HepG2 cells acutely exposed to amiodarone. In conclusion, amiodarone severely inhibits metabolism in primary human mitochondria, which can be counteracted by in-creasing mitochondrial function using intracellular delivery of succinate.</p>}},
  author       = {{Bețiu, Alina M. and Chamkha, Imen and Gustafsson, Ellen and Meijer, Elna and Avram, Vlad F. and Frostner, Eleonor Åsander and Ehinger, Johannes K. and Petrescu, Lucian and Muntean, Danina M. and Elmér, Eskil}},
  issn         = {{1661-6596}},
  keywords     = {{Amiodarone; ATP; Desethylamiodarone; HepG2 cells; Mito-chondria; NV118; PBMCs; Platelets; Respiration; Sotalol}},
  language     = {{eng}},
  month        = {{11}},
  number       = {{21}},
  publisher    = {{MDPI AG}},
  series       = {{International Journal of Molecular Sciences}},
  title        = {{Cell‐permeable succinate rescues mitochondrial respiration in cellular models of amiodarone toxicity}},
  url          = {{http://dx.doi.org/10.3390/ijms222111786}},
  doi          = {{10.3390/ijms222111786}},
  volume       = {{22}},
  year         = {{2021}},
}